Discrete choice experiments in health care

British Medical Journal

Volumn 328, Issue 7436, 2004, Pages 360-361

  Ryan, Mandy ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EDITORIAL; HEALTH CARE; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE;

EID: 1242296189     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7436.360     Document Type: Editorial

References (13)

1. Mooney G. Key issues in health economics. London: Harvester Wheatsheaf, 1994.
2. Ryan M, Gerald K. Using discrete choice experiments to value health care: current practice and future prospects. Appl Health Econ Policy Analysis 2003;2:55-64.
3. Ryan M, Farrar S. Eliciting preference for healthcare using conjoint analysis. BMJ 2000;320:1530-3.
4. Sculpher M, Bryan S, Fry P, de Winter P, Payne H, Emberton M. Patient preferences for the management of non-metastatic prostate cancer: a discrete choice experiment. BMJ 2004;328:382-4.
5. Ryan M, Hughes J. Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ 1997;6:261-73.
6. Ubach C, Scott A, French F, Awramenko M, Needham G. What do hospital consultants value about their jobs? A discrete choice experiment. BMJ 2003;326:1432-42.
7. Farrar S, Ryan M, Ross D, Ludbrook A. Using discrete choice modelling in priority setting: an application to clinical service developments. Soc Sci Med 2000;50:63-75.
8. Viney R, Lancsar E, Louviere J. Discrete choice experiments to measure preferences for health and health care. Exp Rev Pharmacoecon Outcomes Res 2002;2:319-26.
9. Ryan M, Watson V, Amaya-Amaya M. Methodological issues in the monetary valuation of benefits in health care. Exp Rev Pharmacoecon Outcomes Res 2003;3:717-27.
10. National Institute for Clinical Excellence. Guidance for manufacturers and sponsors. London: NICE, 2001. www.nice.org.uk/pdf/technical guidanceformanufacturersandsponsors.pdf (accessed 4 Feb 2004).
11. Insigna R, Fryback D. Understanding differences between self-ratings and population ratings for health in the EuroQOL. Qual Life Res 2003;12:611-9.
12. Vale L, Wyness L, McCormack K, McKenzie L, Brazzelli M, Stearns SC. Systematic review of the effectiveness and cost-effectiveness of metal on metal hip resurfacing arthroplasty for treatment of hip disease. London: National Institute for Clinical Excellence, 2002.
13. Mowatt G, Vale L, Wyness L, Gonzalez-Perez JG, Stearns SC. Systematic review of the effectiveness and cost-effectiveness of home versus hospital or satellite unit haemodialysis for people with end stage renal failure. London: National Institute for Clinical Excellence, 2002.